FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133790240> ?p ?o ?g. }

• W3133790240 endingPage "73" @default.
• W3133790240 startingPage "65" @default.
• W3133790240 abstract "The purpose of this study was to evaluate the therapeutic effects and mechanism of Qufeng Zhitong (QFZT)capsule for the treatment of osteoarthritis (OA) in a rat model.8-10-week-old male Sprague-Dawley rats were randomly divided into the sham group (vehicle-treated), OA group (vehicle-treated), high-dose, middle-dose, low-dose of QFZT capsule-treated groups. OA was induced by transecting the medial collateral ligament and the medial meniscus in the right limb. The Sprague-Dawley rats were treated daily for 12 weeks with different concentrations of QFZT capsule: low (QFZT-L, 128 ​mg/kg), medium (QFZT-M, 256.5 ​mg/kg), and high (QFZT-H, 513 ​mg/kg) by gavage administration for a period of 4 and 12 weeks respectively. Vehicle-treated rats served as controls and administered 0.5% Carboxymethyl Cellulose Sodium (CMC-Na) by gavage on the same schedule. Weekly measurement of dynamic weight-bearing capacity, grip strength, joint swelling was were performed to monitor the progression of disease for 3 weeks. After euthanasia, the knee joints were articular cartilage changes. Pro-inflammatory gene expression in synovial joints was examined to assess the bone and cartilage changes. Gene expression of pro-inflammatory cytokines in synovial joints was measured to determine the therapeutic effect of QFZT.2 weeks after the treatment, the grip strength and weight-bearing capacity were significantly increased in the QFZT-M and QFZT-H groups, compared with the OA group. The joint widths were decreased significantly in the QFZT-L and QFZT- H groups, compared with the OA group as well. The mRNA level in the articular cartilage of knee joint of IL-1β in the QFZT-L group and IL-6 in the QFZT-H group was significantly suppressed at week 4, compared with the OA group. The radiology score was significantly decreased in the QFZT-H group compared with the OA group 12 weeks after treatment. Furthermore, the rats on QFZT treatment decreased the progression of OA, which was characterised by decreased cartilage degradation. However, the bone changes were no different in OA group and QFZT groups.In a rat model of OA, QFZT capsule shows the tendency to reduce the destruction of cartilage, joint swelling and bone erosion which provides new evidence for the therapeutic potential of QFZT capsule in the treatment of OA in clinics.The QFZT capsule can improve the symptoms of the OA in rodent animal rats by attenuating pain and retarding cartilage damage. This study indicated that the QFZT capsule has the potential clinical application of in OA therapy." @default.
• W3133790240 created "2021-03-15" @default.
• W3133790240 creator A5008731105 @default.
• W3133790240 creator A5016223573 @default.
• W3133790240 creator A5019390272 @default.
• W3133790240 creator A5040096220 @default.
• W3133790240 creator A5047818138 @default.
• W3133790240 creator A5048050257 @default.
• W3133790240 creator A5052733243 @default.
• W3133790240 creator A5064222660 @default.
• W3133790240 creator A5072861069 @default.
• W3133790240 creator A5082022764 @default.
• W3133790240 creator A5090883564 @default.
• W3133790240 date "2021-05-01" @default.
• W3133790240 modified "2023-09-29" @default.
• W3133790240 title "The effect and mechanism of QufengZhitong capsule for the treatment of osteoarthritis in a rat model" @default.
• W3133790240 cites W104470354 @default.
• W3133790240 cites W1513858422 @default.
• W3133790240 cites W1963315781 @default.
• W3133790240 cites W1968143755 @default.
• W3133790240 cites W1969327150 @default.
• W3133790240 cites W1970456292 @default.
• W3133790240 cites W1980241739 @default.
• W3133790240 cites W1985363587 @default.
• W3133790240 cites W1988751207 @default.
• W3133790240 cites W2015173447 @default.
• W3133790240 cites W2022991367 @default.
• W3133790240 cites W2038773696 @default.
• W3133790240 cites W2069913139 @default.
• W3133790240 cites W2077612014 @default.
• W3133790240 cites W2078759382 @default.
• W3133790240 cites W2078828283 @default.
• W3133790240 cites W2107894170 @default.
• W3133790240 cites W2114111681 @default.
• W3133790240 cites W2138004638 @default.
• W3133790240 cites W2140899224 @default.
• W3133790240 cites W2162248277 @default.
• W3133790240 cites W2172107520 @default.
• W3133790240 cites W2261237464 @default.
• W3133790240 cites W2359950907 @default.
• W3133790240 cites W2575521580 @default.
• W3133790240 cites W2753676573 @default.
• W3133790240 cites W2809757796 @default.
• W3133790240 cites W2944718957 @default.
• W3133790240 cites W2996917275 @default.
• W3133790240 cites W3002399917 @default.
• W3133790240 cites W3007016757 @default.
• W3133790240 cites W3144620243 @default.
• W3133790240 doi "https://doi.org/10.1016/j.jot.2020.10.013" @default.
• W3133790240 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7932897" @default.
• W3133790240 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33738239" @default.
• W3133790240 hasPublicationYear "2021" @default.
• W3133790240 type Work @default.
• W3133790240 sameAs 3133790240 @default.
• W3133790240 citedByCount "4" @default.
• W3133790240 countsByYear W31337902402021 @default.
• W3133790240 countsByYear W31337902402022 @default.
• W3133790240 crossrefType "journal-article" @default.
• W3133790240 hasAuthorship W3133790240A5008731105 @default.
• W3133790240 hasAuthorship W3133790240A5016223573 @default.
• W3133790240 hasAuthorship W3133790240A5019390272 @default.
• W3133790240 hasAuthorship W3133790240A5040096220 @default.
• W3133790240 hasAuthorship W3133790240A5047818138 @default.
• W3133790240 hasAuthorship W3133790240A5048050257 @default.
• W3133790240 hasAuthorship W3133790240A5052733243 @default.
• W3133790240 hasAuthorship W3133790240A5064222660 @default.
• W3133790240 hasAuthorship W3133790240A5072861069 @default.
• W3133790240 hasAuthorship W3133790240A5082022764 @default.
• W3133790240 hasAuthorship W3133790240A5090883564 @default.
• W3133790240 hasBestOaLocation W31337902401 @default.
• W3133790240 hasConcept C102652120 @default.
• W3133790240 hasConcept C105702510 @default.
• W3133790240 hasConcept C126322002 @default.
• W3133790240 hasConcept C134018914 @default.
• W3133790240 hasConcept C141071460 @default.
• W3133790240 hasConcept C142724271 @default.
• W3133790240 hasConcept C204787440 @default.
• W3133790240 hasConcept C2776164576 @default.
• W3133790240 hasConcept C2778096516 @default.
• W3133790240 hasConcept C2778751288 @default.
• W3133790240 hasConcept C2778778583 @default.
• W3133790240 hasConcept C2779753412 @default.
• W3133790240 hasConcept C2780423099 @default.
• W3133790240 hasConcept C2780550940 @default.
• W3133790240 hasConcept C59822182 @default.
• W3133790240 hasConcept C71924100 @default.
• W3133790240 hasConcept C86803240 @default.
• W3133790240 hasConceptScore W3133790240C102652120 @default.
• W3133790240 hasConceptScore W3133790240C105702510 @default.
• W3133790240 hasConceptScore W3133790240C126322002 @default.
• W3133790240 hasConceptScore W3133790240C134018914 @default.
• W3133790240 hasConceptScore W3133790240C141071460 @default.
• W3133790240 hasConceptScore W3133790240C142724271 @default.
• W3133790240 hasConceptScore W3133790240C204787440 @default.
• W3133790240 hasConceptScore W3133790240C2776164576 @default.
• W3133790240 hasConceptScore W3133790240C2778096516 @default.
• W3133790240 hasConceptScore W3133790240C2778751288 @default.
• W3133790240 hasConceptScore W3133790240C2778778583 @default.

• next